News

22 June 2023

BAP Pharma Recipients of Thames Valley 250 Awards

BAP Pharma are the honoured recipients of the Thames Valley 250 ‘CEO of the Year (over £50m)‘ and ‘Fast Riser of the Year‘ awards.

The Thames Valley 250 is an annual listing, compiled by The Business Magazine, that celebrates the top independent, privately-owned businesses located in the Thames Valley region, ranked by annual sales turnover.

This is the second consecutive year that BAP Pharma has received an award from Thames Valley 250, having been previously presented with the ‘Special Recognition’ award and we also take great pride in our ranking rising from 47th to our highest position of 24th in 2022.
 

CEO of the Year (over £50m) award – sponsored by Verlingue

Awarded in recognition of the outstanding achievements of a CEO/Managing Director and the wider team in growing the business, driving innovation and developing the brand and company culture.

“This company is currently achieving unbelievable results evidenced by their surge up this year’s listing. There is a very clear strategy centred around excellence, innovation and delivering exceptional customer service. Their success is very much down to the highly skilled and experienced leadership team that Bashir recognised the need for and has built around him.”

Judge’s Feedback.

“We have grown a lot in the last year and that is down to the dedication and passion of all our employees for customer service. It is one of my key principles and beliefs. It gives staff a sense of pride to receive recognition from our clients for their excellent service, which is really motivating. I’ve built a leadership team around me who buy into my vision and principles and have recruited the very best to help me carry out my mission.”

Dr. Bashir Pakar, Founder and Managing Director of BAP Pharma.

 

Fast Riser of the Year award – sponsored by Gateley Legal

Awarded in recognition of a privately-owned business that has grown considerably year-on-year, with a compelling story to tell, such as growth by strategic acquisition, product diversification and exploring new markets.

“The winner has achieved impressive growth duelled by its visionary approach, which encompasses innovation, quality and accessibility, as it strives to develop cutting-edge medications that address unmet medical needs. With a steadfast commitment to improving global healthcare, the company has expanded its product offerings and geographical presence. By continuously adapting to industry trends and customer demands, it remains at the forefront of pharmaceutical innovation, dedicated to making a positive impact on human health.”

Judge’s Feedback.

“A key part of our approach to business is to have respect for customer, suppliers and staff. I passionately believe in having a harmonious environment. People have got to enjoy coming to work and they wouldn’t if we didn’t have respect for one another. The business is at the cutting edge and works hard to stay there by getting medicines to patients with unmet clinical needs. We distribute all around the world and go the extra mile to get medicines to people who need them.”

Dr. Bashir Pakar, Founder and Managing Director of BAP Pharma.

 

Please click here to read the full Business Magazine article

You Might Also Like

BAP Pharma Announces Grand Opening Ceremony for New US Headquarters in Somerset, NJ

BAP Pharma announced today that the Grand Opening Ceremony of its new US headquarters will be held on Wednesday, 24th of April 2024. SOMERSET, N.J.– (BUSINESS WIRE) – BAP Pharma will welcome guests and dignitaries to the Grand Opening Ceremony of its new headquarters on Randolph Road with a formal

BAP Pharma Announces Grand Opening Ceremony for New US Headquarters in Somerset, NJ

BAP Pharma Granted Clinical Secondary Packaging and Labelling Licence

BAP Pharma are pleased to announce that the Government of Upper Bavaria (Regierung von Oberbayern) have granted a Clinical Secondary Packaging and Labelling licence, to our German facility. The new licence will enable BAP Pharma to offer bespoke Clinical Trial Secondary Packaging and Labelling services, to complement our award-winning Comparator

BAP Pharma Granted Clinical Secondary Packaging and Labelling Licence

Minority Supplier Development UK Report 2021

We are excited and proud to announce that BAP Pharma have ranked 78th in the Minority Supplier Development UK Report 2021 – the first ever list of the country’s top 100 minority businesses. The Minority Supplier Development UK (MSDUK) is the UK’s premier not-for-profit membership organisation, championing diversity and inclusion

Minority Supplier Development UK Report 2021